11 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
in vitro culture approaches and traditional in vivo animal models and testing. We also face future competition from companies developing cannabinoid
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
in vitro culture approaches and traditional in vivo animal models and testing. We also face future competition from companies developing cannabinoid
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
and competitive lead in our industry.
Competition arises mainly from two sources, traditional cell-based in vitro culture approaches and traditional in vivo
S-1
8ry694m619
29 Jun 23
IPO registration
4:39pm
DRS/A
7n67u3ziyaqjhp
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
b24c12uhcn6zxag nq33
2 May 23
Draft registration statement (amended)
12:00am
DRS
vnx3702ay p3xcpi
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next